feed,title,long_url,short_url
SeekingAlpha,FDA expands breakthrough status for CymaBay's seladelpar,https://seekingalpha.com/news/4022836,
SeekingAlpha,"Sentiment Speaks: I Am Still Bullish, Unless",https://seekingalpha.com/article/4642485,
SeekingAlpha,Sitio Royalties: New Notes Reduce Interest Costs By Around $15 Million Per Year,https://seekingalpha.com/article/4642609,
